Steven Cohen’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
Steven Cohen's LFCR Position: Q3 2026 in Review
Steven Cohen sold out of Lifecore Biomedical (LFCR) in Q3 2026, closing a stake of 52,520 shares — an estimated $276K sold.
Steven Cohen first reported a position in LFCR in Q4 2021 and held it in 8 quarters. The position peaked at $3.03M in Q1 2022. 105 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.
- Steven Cohen reported no remaining Lifecore Biomedical position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 52,520 Lifecore Biomedical shares in Q3 2026, an estimated $276K.
- Steven Cohen first reported a position in Lifecore Biomedical in Q4 2021 and held it in 8 quarters.
- Steven Cohen's Lifecore Biomedical position peaked at $3.03M in Q1 2022.
- 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.